[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609797":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":33,"locations":43,"responsibleParty":60,"collaborators":65,"id":71,"slug":72,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":77,"eligibilityCriteria":78,"healthyVolunteers":73,"sex":79,"minAge":80,"maxAge":26,"enrollmentInfo":81,"targetDuration":26,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":95,"overallStatus":46,"whyStopped":26,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"Palo Alto Veterans Institute for Research","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Usual Care - Arm A","ACTIVE_COMPARATOR","Patients randomized to this group will receive usual care provided by their oncology(or primary) clinical team.",[13],"Other: Usual Care Group",{"label":15,"type":16,"description":17,"interventionNames":18},"Intervention Lay Health Worker (LHW) - Arm B","EXPERIMENTAL","Participants randomized to this arm of the study will receive usual care with supplemental education and support provided by a lay health worker (LHW) to assist with healthcare planning, symptom management, and discussions about care preferences and goals.",[19],"Behavioral: Lay Health Worker (LHW) Planning",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"BEHAVIORAL","Lay Health Worker (LHW) Planning","Patients randomized to the LHW group will receive usual care provided by their oncology (or primary) clinical team along with an initial 30-minute telephone call with the LHW from Palo Alto, followed by weekly 15-minute phone calls (or as needed) for 6months. These calls are designed to assist with healthcare planning, symptom management, and discussions about care preferences and goals.",[15],null,{"type":6,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"Usual Care Group","Participants randomized to the usual care group will receive usual care provided by their oncology clinical team. These teams have been trained in symptom assessment, goals-of-care (GoC) discussions, and documentation of such clinical services. As part of usual care, participants may engage in symptom and GoC discussions at any time, initiated by either the patient or the clinician.",[9],[32],"Usual Care",[34,39],{"name":35,"role":36,"phone":37,"phoneExt":26,"email":38},"Manali I Patel, MD MPH MS","CONTACT","6504935000","manalip@stanford.edu",{"name":40,"role":36,"phone":41,"phoneExt":26,"email":42},"Madhuri Agrawal, MS","650-304-7744","madhuri.agrawal@va.gov",[44],{"facility":45,"status":46,"city":47,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"Veterans Affairs Palo Alto Health Care System (VAPAHCS)","RECRUITING","Palo Alto","California","94304","United States","US",{"type":53,"coordinates":54},"Point",[55,56],-122.14302,37.44188,{"lat":56,"lon":55},[59],{"name":40,"role":36,"phone":41,"phoneExt":26,"email":42},{"type":61,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":64,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Manali Patel","Staff Oncologist and Investigator","VA Palo Alto Health Care System",[66,69],{"name":67,"class":68},"United States Department of Defense","FED",{"name":70,"class":68},"US Department of Veterans Affairs","100609797","engagement-of-veterans-with-lung-cancer-100609797",false,"NCT07219251","Engagement of Veterans With Lung Cancer","Engagement of Veterans With Lung Cancer (EVLC)","EVLC","Inclusion Criteria:\n\n1. Veteran patients with diagnosis of any stage of lung cancer;\n2. 18 years of age or older;\n3. English- or Spanish-speaking;\n4. can self-administer questionnaires in English or Spanish;\n5. valid telephone number;\n6. receiving oncology care at participating sites;\n7. currently newly diagnosed or receiving or having completed systemic anti-cancer therapy and\u002For radiation therapy within 12 months, defined as oral, injection, or intravenous therapy (chemotherapy, targeted therapy, or immunotherapy)\n\nExclusion Criteria:\n\n1. no capacity to consent;\n2. actively receiving hospice care","ALL","18 Years",{"count":82,"type":83},194,"ESTIMATED","INTERVENTIONAL",[86],"NA","This research study will help our understanding of whether additional support for Veterans with lung cancer can improve their quality of life.",[89,90,91,92,93,94],"Lung Cancer (NSCLC)","Lung Adenocarcinoma","Lung Cancer, Non-Small Cell","Lung Carcinoma","Lung Cancer, Small Cell","Lung Adenocarcinoma With Bronchiolo-alveolar Feature",[96,97],"lung","cancer","2026-03-02",{"date":100,"type":101},"2026-03-03","ACTUAL",{"date":103,"type":101},"2026-02-27",{"date":105,"type":83},"2032-12-31",{"name":5,"class":6},1]